Showing results (61-70 of 451) with videos related to
Sort By:
Pageof 46
Folia Biologica|January 1, 1996
Cytokine-based gene therapy of human tumors. An overviewG Parmiani, F Arienti, J Sulé-Suso, et al.Immunology Today|April 1, 1990
An explanation of the variable clinical response to interleukin 2 and LAK cellsG ParmianiThe Keio Journal of Medicine|July 14, 2001
Melanoma antigens and their recognition by T cellsG ParmianiExperimental and Clinical Immunogenetics|January 1, 1987
Ly-5.185 molecule is associated with thymic maturation of lymphocytes but not with their cytotoxic activityC Traversari, G Ferrari, L Grazioli, et al.European Journal of Immunology|August 1, 1985
Disulfide-linked surface molecules of monoclonal antigen-specific suppressor T cells: evidence for T cell receptor structuresD Ballinari, C Castelli, C Traversari, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1996
Binding and presentation of peptides derived from melanoma antigens MART-1 and glycoprotein-100 by HLA-A2 subtypes. Implications for peptide-based immunotherapyL Rivoltini, D J Loftus, K Barracchini, et al.The Journal of Experimental Medicine|October 1, 1993
T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL cloneM Sensi, S Salvi, C Castelli, et al.Journal of the National Cancer Institute|November 1, 1975
Nonimmunogenic sarcomas induced by 3-methylcholanthrene treatment of murine fibroblasts in diffusion chambersG Carbone, G ParmianiInternational Journal of Cancer|November 15, 1975
Alien histocompatibility determinants on the cell surface of sarcomas induced by methylcholanthrene. I. In vivo studiesG Parmiani, G InvernizziTumori|September 1, 1976
Syngeneic antitumor and antiembryo immunization affecting pregnancy in miceR Lembo, G ParmianiPageof 46